Lcnb Corp Becton Dickinson & CO Transaction History

Lcnb Corp

$281 Million
Q3 2024

A detailed history of Lcnb Corp transactions in Becton Dickinson & CO stock. As of the latest transaction made, Lcnb Corp holds 2,895 shares of BDX stock, worth $660,407. This represents 0.25% of its overall portfolio holdings.

Number of Shares

2,895

Previous 2,750 5.27%

Holding current value

$660,407

Previous $642,000 8.57%

% of portfolio

0.25%

Previous 0.24%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$221.47 - $242.41 $32,113 - $35,149	145 Added 5.27%	2,895 $697,000
Q1 2024 May 10, 2024	BUY	$233.45 - $247.73 $20,310 - $21,552	87 Added 3.27%	2,750 $680,000
Q4 2023 Feb 12, 2024	BUY	$232.24 - $267.23 $42,267 - $48,635	182 Added 7.34%	2,663 $649,000
Q2 2023 Aug 14, 2023	BUY	$238.39 - $265.32 $30,990 - $34,491	130 Added 5.53%	2,481 $655,000
Q1 2023 May 03, 2023	BUY	$229.71 - $259.35 $45,942 - $51,870	200 Added 9.3%	2,351 $581,000
Q4 2022 Feb 10, 2023	BUY	$218.29 - $256.91 $42,348 - $49,840	194 Added 9.91%	2,151 $547,000
Q3 2022 Nov 14, 2022	BUY	$51.03 - $264.23 $408 - $2,113	8 Added 0.41%	1,957 $436,000
Q2 2022 Aug 12, 2022	BUY	$234.74 - $275.42 $93,896 - $110,168	400 Added 25.82%	1,949 $480,000
Q1 2022 May 13, 2022	BUY	$243.64 - $270.48 $131,565 - $146,059	540 Added 53.52%	1,549 $412,000
Q4 2021 Feb 14, 2022	BUY	$230.08 - $250.94 $232,150 - $253,198	1,009 New	1,009 $254,000
Q4 2018 Feb 19, 2019	SELL	$204.73 - $257.93 $189,784 - $239,101	-927 Closed	0 $0
Q2 2018 Aug 13, 2018	BUY	$208.1 - $233.85 $192,908 - $216,778	927 New	927 $222,000

Others Institutions Holding BDX

# of Institutions

1,738

Shares Held

249M

Call Options Held

690K

Put Options Held

787K

View Full List

About BECTON DICKINSON & CO

Ticker BDX
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 285,195,008
Market Cap $65.1B
Description
Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...

More about BDX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Lcnb Corp, based on Form 13F filings with the SEC.

News

Stay updated on Lcnb Corp with notifications on news.

Account